114 results on '"Diabetes therapy -- Intellectual property -- Reports"'
Search Results
2. Patent Issued for User interface for diabetes management system (USPTO 11929158)
3. Patent Issued for Multi-rate analyte sensor data collection with sample rate configurable signal processing (USPTO 12171548)
4. Researchers Submit Patent Application, 'Glucose-Responsive Insulin Conjugates Comprising A Tetra-Valent Sugar Cluster For Treatment Of Diabetes', for Approval (USPTO 20240424109)
5. Patent Issued for Microneedle-array patches with glucose-responsive matrix for closed-loop insulin delivery (USPTO 12161749)
6. Patent Issued for Medical device alert, optimization, personalization, and escalation (USPTO 12154427)
7. Researchers Submit Patent Application, 'Management Process For Insulin Therapy Using Reinforcement Learning And Therapy Escalation Pathways', for Approval (USPTO 20240339190)
8. Patent Issued for Pen needle removal device for a drug delivery device (USPTO 11786670)
9. Patent Issued for Adapter for a fluid transfer device (USPTO 12042469)
10. Patent Issued for Pen needle assembly apparatus (USPTO 11744957)
11. Patent Issued for PD-L1 expressing hematopoietic stem cells and uses (USPTO 11642378)
12. Patent Issued for Insulin management (USPTO 12027266)
13. Researchers Submit Patent Application, 'Intestinal Sleeve', for Approval (USPTO 20240180730)
14. Patent Issued for Detection of audible alerts (USPTO 11992657)
15. 'Hb-Egf Gene Therapy For Diabetes' in Patent Application Approval Process (USPTO 20240173381)
16. Patent Issued for Residual compensation including underfill error (USPTO 11988626)
17. Researchers Submit Patent Application, 'Transitioning To Other Modes In Automated Insulin Delivery', for Approval (USPTO 20240157052)
18. Patent Issued for Display for pump (USPTO 11967292)
19. Patent Issued for Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome (USPTO 11957652)
20. Patent Issued for Isolation of bona fide pancreatic progenitor cells (USPTO 11613736)
21. Patent Issued for Drug injection device with deflectable transducer (USPTO 11931556)
22. Patent Issued for Use of metformin and analogs thereof to reduce RAN protein levels in the treatment of neurological disorders (USPTO 11903910)
23. Patent Issued for Closed loop control of physiological glucose (USPTO 11878145)
24. Researchers Submit Patent Application, 'Location-Aided Glycemic Control', for Approval (USPTO 20240021284)
25. Researchers Submit Patent Application, 'Insulin Management', for Approval (USPTO 20240013913)
26. Patent Issued for Conjugate based systems for controlled insulin delivery (USPTO 11413352)
27. Researchers' from Jiangnan University Report Details of New Studies and Findings in the Area of Data Analytics (Patent information analysis of TCM prescription for the treatment of diabetes based on patent analysis and SWOT model)
28. 'Low-Dose Hepatocyte Growth Factor Gene Therapy For Diabetes' in Patent Application Approval Process (USPTO 20230414718)
29. Patent Issued for Type I diabetes therapy (USPTO 11806386)
30. Patent Issued for Sensor inserter having introducer (USPTO 11160475)
31. Patent Issued for Integrated insulin delivery system with continuous glucose sensor (USPTO 11744943)
32. Patent Issued for Fluid drug cartridge type identification (USPTO 11129932)
33. Patent Issued for Medical device with battery testing (USPTO 11686774)
34. Patent Issued for Controlled Induction Of Human Pancreatic Progenitors Produces Functional Beta-Like Cells (USPTO 10,975,355)
35. Patent Issued for Spiro And Cyclic Bis-Benzylidene Proteasome Inhibitor For The Treatment Of Cancer, Diabetes And Neurological Disorders (USPTO 10,947,199)
36. Researchers Submit Patent Application, 'Pen Needle Removal Device For A Drug Delivery Device', for Approval (USPTO 20200368450)
37. Patent Issued for Use Of Noggin, An ALK5 Inhibitor And A Protein Kinase C Activator To Produce Endocrine Cells (USPTO 10,704,025)
38. Patent Issued for Islet Amyloid Polypeptides With Improved Solubility (USPTO 10,683,333)
39. Patent Issued for Pharmaceutical Composition Containing 8-[(3R)-3-Amino-1-Piperidinyl]-7-(2-Butyn-1-Yl)-3,7-Dihydro-3-Methyl-1-[4- -Methyl-2-Quinazolinyl)methyl]-1H-Purine-2,6-Dione Or A Pharmaceutically Acceptable Salt (USPTO 10,668,073)
40. Patent Issued for Oxabicycloheptanes And Oxabicycloheptenes For The Treatment Of Diabetes (USPTO 10,668,062)
41. Patent Issued for Infusion systems (USPTO 11617829)
42. Patent Issued for Reconfigurable measurement system (USPTO 11598763)
43. Patent Issued for Diabetes management therapy advisor (USPTO 11574742)
44. Researchers from Guang'anmen Hospital Report Details of New Studies and Findings in the Area of Insulin Resistance (The Efficacy of Chinese Patent Medicine Intervention On Blood Glucose and Lipid In Prediabetes: a Meta-analysis)
45. Patent Issued for Compositions for use in the treatment of diabetes (USPTO 11541019)
46. Patent Issued for Medical software download to mobile phone (USPTO 11494172)
47. Patent Issued for Display for pump (USPTO 11488549)
48. Patent Issued for Optimizing analyte sensor calibration (USPTO 11464434)
49. Patent Issued for Flow detector (USPTO 11446436)
50. Patent Issued for Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent (USPTO 11439326)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.